OPCH

$29.75

Post-MarketAs of Mar 17, 8:00 PM UTC

Option Care Health, Inc.

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

Zacks
Mar 17, 2026

4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts

An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 12, 2026

3 Russell 2000 Stocks We Steer Clear Of

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

1 Stock Under $50 for Long-Term Investors and 2 We Turn Down

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 28, 2026

A Look At Option Care Health’s Valuation As 2025 Results And 2026 Guidance Signal Resilient Growth

Option Care Health (OPCH) is back in the spotlight after releasing fourth quarter and full year 2025 results. The company reported higher sales, steady profitability, active share repurchases, and updated 2026 guidance despite ongoing reimbursement and biosimilar pressures. See our latest analysis for Option Care Health. The latest earnings release has come alongside some share price volatility, with a 1 day share price return of 1.79% after the results, a 7 day share price return of 9.05%...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.